The largest database of trusted experimental protocols

10 protocols using anti vwf

1

Quantifying Neurogenesis and Angiogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Five weeks after treatment, animals were sacrificed and subjected to transcardial
perfusion with PBS and 4% paraformaldehyde. Brains were removed, stored in 4%
paraformaldehyde at 4 °C overnight, and immersed in 30% sucrose for 3 to 4 d at 4 °C.
Brains were then frozen rapidly in powdered dry ice and stored at −70 °C. Frozen brains
were sectioned coronally between 3 and 4 mm posterior to the bregma to a thickness of 18
µm using a Cryocut Microtome (Leica Microsystems). The neurogenetic and angiogenetic
effects of hMSCs were measured by immunofluorescence staining as previously described10 (link). All rats received 5-bromo-2′-deoxyuridine (50 mg/kg, intraperitoneal, BrdU; Roche
Holding AG, Basel, Switzerland) injections per day for the last week. Neurogenesis and
angiogenesis effects were calculated using immunostaining with mouse anti-BrdU (diluted
1:50, Abcam, Cambridge, United Kingdom)/rabbit anti-doublecortin (anti-DCX, diluted 1:200,
Abcam) or rabbit anti–von Willebrand factor (anti-vWF, diluted 1:200, Chemicon, Temecula,
CA, USA). Images were acquired with an EVOS fl microscope (Advanced Microscopy Group). The
number of BrdU/DCX double-positive cells was measured with Image (National Institutes of
Health, Bethesda, MD, USA). The area of vWF was analyzed using Multi Gauge (Fuji Photo
Film Co. Ltd., Tokyo, Japan).
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of Angiogenic Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
To block non-specific binding sites, 5% bovine serum albumine (BSA), 10% Goat Serum (GS) or 0.75% Horse Serum (HS) were used. Sections were incubated overnight at 4 °C with primary antibodies: polyclonal anti-VEGFA (Santa Cruz, sc-7269) (1:250 in 1% BSA), polyclonal anti-VEGFR2 (Invitrogen, AHR5102) (1:250 in 1% BSA), polyclonal anti IBA-1 (Wako Pure Chemical Industries, 019-19741) (1:200 in 1% GS), monoclonal bFGF (Millipore 2718303) (1:200 in 0,75% HS), monoclonal FGFR1 (OriGene TA324059) (1:250 in 1% GS) and plyclonal anti-vWF (Chemicon, AB7356) (1:250 in 1% BSA). All the antibodies used in this paper are summarized in Supplementary Table S1. Secondary antibodies were anti-mouse or anti-rabbit IgG conjugated to red or green fluorescent dies (Alexa Fluor 594 or 488; Molecular Probes, Invitrogen, Carlsbad, CA) diluted 1:1000 and incubated at 37 °C for 2 h. Anti-mouse IgG conjugated to red fluorescent dye was used for anti-VEGFA; anti-mouse IgG conjugated to green fluorescent dye was used for anti-VEGFR2 and anti-bFGF; anti-rabbit IgG conjugated to red fluorescent dye was used for anti-FGFR1, anti-IBA-1 and anti-vWF. Images of immunolabeled cryosections were acquired by using a Leica TCS SP5 confocal microscope.
+ Open protocol
+ Expand
3

Histological Analysis of Grafted Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fourteen days after the grafting procedure, 4 eyes receiving grafts in each group were enucleated and fixed in 10% formaldehyde solution. The samples were embedded in paraffin for preparation of 3 microns paraffin-embodied sectioned. Then, slides with sections were deparaffinized performed with hematoxylin and eosin (H&E) staining for histological examination. For immunohistological analysis, the slides were also deparaffinized and then processed for immunohistochemical staining with anti-CD4(Sigma) and anti-vWF(Sigma) according to the previous reported [17] (link) antibodies. Briefly, after deparaffinization, the slides were rehydrated and heat-induced antigen retrieval was performed. After blocking with 10% normal horse serum for 15 min, the sections were immunostainned using the primary antibodies and incubated overnight at 4°C. The redundant antibodies were washed with Phosphate Buffered Saline. The corresponding secondary antibodies were added and incubated for 2 hours at room temperature.
+ Open protocol
+ Expand
4

Evaluating P-gp and eEF-2K Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
P-gp, eEF-2K, phospho-eEF-2 (Thr56) monoclonal antibody was purchased from Abcam Chemical Co. (Cambridge, UK). Fluorescein isothiocyanate (FITC)-labeled rabbit anti-rat IgG was purchased from Jackson Immunoresearch (West Grove, PA, USA). NH125, L-glutamate, MK-801, N-acetylcysteine and anti-vWF were obtained from Sigma Chemical Co. (St. Louis, MO, USA). All other chemicals were of analytical grade and are commercially available.
+ Open protocol
+ Expand
5

Immunofluorescence Staining of HSPG2 and vWF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunofluorescence was performed with pulmonary tissues and HUVECs. Samples were fixed in 4% paraformaldehyde, blocked with donkey serum (Solarbio, Beijing), and incubated with anti-HSPG2 (Abcam, cat. no. ab2501) and anti-vWF (von Willebrand factor, Sigma‐Aldrich, cat. no. AB7356). After incubating with a second antibody (Alexa Fluor® 488 or 594) (1:200) and 4’,6‐diamidino‐2‐phenylindole (Abcam), we observed them with confocal microscopy (Nikon).
+ Open protocol
+ Expand
6

Mouse Lung Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
BrdU (75 mg/kg BW, Sigma-Aldrich) was intraperitoneally injected to mice 4 h prior to tissue collection. Mouse lung cryosections (6 µm thick) were stained with FITC-conjugated anti-BrdU antibody using the In Situ Cell Proliferation kit (Roche Diagnostics) [31] (link) and nuclei were counterstained with DAPI. Anti-vWF (1∶300, Sigma) and anti-CD31 antibodies (1∶40, Abcam, Cambridge, MA) were used to identify endothelial cells.
+ Open protocol
+ Expand
7

Cerebral Vascular Morphology Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The rat brains collected at different time points after MCAO were harvested and sectioned at 10 µm in thickness. Following fixation with 4% paraformaldehyde, the brain slice was incubated in 100 μL blocking serum (10% fetal bovine serum in 0.2% PBST) for 1 h. Cerebral vasculature was stained with primary antibody anti-vWF (AB7356, 1:200, Milipore, Burlington, MA, USA), followed by Alexa Fluor 594 conjugated secondary antibody. Images were visualized by a confocal microscope (Fluoview BX61, Olympus, Tokyo, Japan). ImageJ was used to capture the change in vascular morphology. The total vascular area per image was quantified by ImageJ, and the average vascular diameter was determined using the shortest Feret diameter (Feret Min) as described previously [42 (link)].
+ Open protocol
+ Expand
8

Immunofluorescence Staining of Brain Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunofluorescence staining was performed on the fixed frozen brain sections as previously described26 (link). Sections were incubated overnight at 4°C with the anti-SMemb (Abcam), or the anti- alpha-SMA (Santa Cruz Biotechnology) with the anti-vWF (Millipore, Temecula, CA), followed by appropriate fluorescence dye-conjugated secondary antibodies (Jackson Immunoresearch, West Grove, PA) for 2 hours at room temperature. The sections were visualized with a fluorescence microscope (Olympus OX51, Tokyo, Japan).
+ Open protocol
+ Expand
9

Histological Analysis of Neonatal Hypoxia-Ischemia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anesthetized pups were transcardially perfused with 0.1 M PBS followed by 4% formaldehyde solution (PFA) 48 hours after HI. The brains were then removed, postfixed (4% PFA, 4°C, 24 hr), and then transferred into a 30% sucrose solution for 2 days. The cryoprotected brains were sectioned at a thickness of 10 µm with a cryostat (LM3050S, Leica Microsystems Inc, IL, USA) for double fluorescence staining. The sections were then washed three times with 0.1 M PBS and were incubated with blocking solution (10% normal goat serum in 0.1 M PBS) for 2 hours at room temperature following 0.1%Triton X-100 (37°C, 30 min). Primary antibodies anti-GFAP (1:200, Millipore, Billerica, MA, USA), anti-vWF (1:200, Millipore, Billerica, MA, USA), anti-G-CSFR (1:100, Santa Cruz Biotechnology, Inc., CA, USA), anti-p-GSK-3β (Tyr216,1:200, abcam, Cambridge, MA,USA), anti-β-Catenin (1:200, abcam, Cambridge, MA, USA), anti-MPO (1:100, Santa Cruz Biotechnology, Inc., CA, USA), and DAPI (Vector Laboratories Inc. Burlingame, CA, USA) were applied (4°C, overnight).
The sections were then washed with 0.1 M PBS and incubated for 2 hours with secondary antibodies (1:200, anti-mouse IgG labeled with Alexa Fluor-488, anti-rabbit IgG labeled with Alexa Fluor-568, Jackson ImmunoResearch Laboratories, Inc. West Grove, PA, USA) at room temperature. The stained slices were observed with an OLYMPUS BX51 microscope.
+ Open protocol
+ Expand
10

Immunohistochemical Profiling of Angiogenesis and Bone Formation

Check if the same lab product or an alternative is used in the 5 most similar protocols
IHC staining of endothelial vessels for von Willebrand factor (vWF) and osteogenic factors BMP-2 was then performed. Briefly, the sections were treated with 1 mg/mL pronase (Sigma-Aldrich, Missouri, USA) for 30 min and then incubated overnight at 4°C with a polyclonal rabbit anti-vWF (dilution 1:700; Millipore, MA, USA), anti-BMP-2 (dilution 1:700; Bioss Antibodies, MA, USA), anti-collagen I (dilution 1:100; Novus Biologicals, CO, USA) and anti-osteocalcin (dilution 1:100; Santa Cruz Biotechnology, CA, USA) antibodies, respectively. Secondary antibody goat anti-rabbit biotinylated immunoglobulin (dilution 1:1000; DakoCytomation, Denmark) was then applied for 60 min at 37°C. Streptavidin peroxidase (Vector Laboratories, Burlingame, US) was applied at a 1:1000 dilution for 60 min at 37°C. The peroxidase activity was detected using 0.4 mg/L of 3.3'-diaminobenzidine in a phosphate buffer, pH of 7.3, in the presence of 0.12% H2O2. The immunostaining signals were also measured using Image-Pro Plus 5.0 software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!